Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 2
2010 7
2011 4
2012 3
2013 9
2014 11
2015 7
2016 9
2017 17
2018 21
2019 17
2020 16
2021 20
2022 16
2023 23
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Results by year

Filters applied: . Clear all
Page 1
A meta-analysis of cytokines in major depression.
Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctôt KL. Dowlati Y, et al. Among authors: swardfager w. Biol Psychiatry. 2010 Mar 1;67(5):446-57. doi: 10.1016/j.biopsych.2009.09.033. Epub 2009 Dec 16. Biol Psychiatry. 2010. PMID: 20015486
Efficacy of non-invasive brain stimulation on global cognition and neuropsychiatric symptoms in Alzheimer's disease and mild cognitive impairment: A meta-analysis and systematic review.
Teselink J, Bawa KK, Koo GK, Sankhe K, Liu CS, Rapoport M, Oh P, Marzolini S, Gallagher D, Swardfager W, Herrmann N, Lanctôt KL. Teselink J, et al. Among authors: swardfager w. Ageing Res Rev. 2021 Dec;72:101499. doi: 10.1016/j.arr.2021.101499. Epub 2021 Oct 23. Ageing Res Rev. 2021. PMID: 34700007
Soluble Epoxide Hydrolase and Diabetes Complications.
Anita NZ, Swardfager W. Anita NZ, et al. Among authors: swardfager w. Int J Mol Sci. 2022 Jun 2;23(11):6232. doi: 10.3390/ijms23116232. Int J Mol Sci. 2022. PMID: 35682911 Free PMC article. Review.
Sex differences in associations between APOE ε2 and longitudinal cognitive decline.
Wood ME, Xiong LY, Wong YY, Buckley RF, Swardfager W, Masellis M, Lim ASP, Nichols E, Joie R, Casaletto KB, Kumar RG, Dams-O'Connor K, Palta P, George KM, Satizabal CL, Barnes LL, Schneider JA, Binet AP, Villeneuve S, Pa J, Brickman AM, Black SE, Rabin JS; ADNI and Prevent-AD Research Groups. Wood ME, et al. Among authors: swardfager w. Alzheimers Dement. 2023 Oct;19(10):4651-4661. doi: 10.1002/alz.13036. Epub 2023 Mar 30. Alzheimers Dement. 2023. PMID: 36994910
Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease.
Shirzadi Z, Schultz SA, Yau WW, Joseph-Mathurin N, Fitzpatrick CD, Levin R, Kantarci K, Preboske GM, Jack CR Jr, Farlow MR, Hassenstab J, Jucker M, Morris JC, Xiong C, Karch CM, Levey AI, Gordon BA, Schofield PR, Salloway SP, Perrin RJ, McDade E, Levin J, Cruchaga C, Allegri RF, Fox NC, Goate A, Day GS, Koeppe R, Chui HC, Berman S, Mori H, Sanchez-Valle R, Lee JH, Rosa-Neto P, Ruthirakuhan M, Wu CY, Swardfager W, Benzinger TLS, Sohrabi HR, Martins RN, Bateman RJ, Johnson KA, Sperling RA, Greenberg SM, Schultz AP, Chhatwal JP; Dominantly Inherited Alzheimer Network and the Alzheimer’s Disease Neuroimaging Initiative. Shirzadi Z, et al. Among authors: swardfager w. JAMA Neurol. 2023 Dec 1;80(12):1353-1363. doi: 10.1001/jamaneurol.2023.3618. JAMA Neurol. 2023. PMID: 37843849
Blood-brain barrier opening of the default mode network in Alzheimer's disease with magnetic resonance-guided focused ultrasound.
Meng Y, Goubran M, Rabin JS, McSweeney M, Ottoy J, Pople CB, Huang Y, Storace A, Ozzoude M, Bethune A, Lam B, Swardfager W, Heyn C, Abrahao A, Davidson B, Hamani C, Aubert I, Zetterberg H, Ashton NJ, Karikari TK, Blennow K, Black SE, Hynynen K, Lipsman N. Meng Y, et al. Among authors: swardfager w. Brain. 2023 Mar 1;146(3):865-872. doi: 10.1093/brain/awac459. Brain. 2023. PMID: 36694943 Free PMC article.
Interleukin-17 in post-stroke neurodegeneration.
Swardfager W, Winer DA, Herrmann N, Winer S, Lanctôt KL. Swardfager W, et al. Neurosci Biobehav Rev. 2013 Mar;37(3):436-47. doi: 10.1016/j.neubiorev.2013.01.021. Epub 2013 Jan 28. Neurosci Biobehav Rev. 2013. PMID: 23370232 Review.
Glucose-lowering drugs, cognition, and dementia: The clinical evidence.
Wu CY, Shapiro L, Ouk M, MacIntosh BJ, Black SE, Shah BR, Swardfager W. Wu CY, et al. Among authors: swardfager w. Neurosci Biobehav Rev. 2022 Jun;137:104654. doi: 10.1016/j.neubiorev.2022.104654. Epub 2022 Apr 6. Neurosci Biobehav Rev. 2022. PMID: 35398114 Review.
Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET.
Ottoy J, Ozzoude M, Zukotynski K, Adamo S, Scott C, Gaudet V, Ramirez J, Swardfager W, Cogo-Moreira H, Lam B, Bhan A, Mojiri P, Kang MS, Rabin JS, Kiss A, Strother S, Bocti C, Borrie M, Chertkow H, Frayne R, Hsiung R, Laforce RJ, Noseworthy MD, Prato FS, Sahlas DJ, Smith EE, Kuo PH, Sossi V, Thiel A, Soucy JP, Tardif JC, Black SE, Goubran M; Medical Imaging Trial Network of Canada (MITNEC) and Alzheimer's Disease Neuroimaging Initiative (ADNI). Ottoy J, et al. Among authors: swardfager w. Alzheimers Dement. 2023 Apr;19(4):1503-1517. doi: 10.1002/alz.12750. Epub 2022 Sep 1. Alzheimers Dement. 2023. PMID: 36047604
154 results